664 related articles for article (PubMed ID: 24643131)
1. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.
Wong J; Piceno YM; DeSantis TZ; Pahl M; Andersen GL; Vaziri ND
Am J Nephrol; 2014; 39(3):230-237. PubMed ID: 24643131
[TBL] [Abstract][Full Text] [Related]
2. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.
Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J
J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251
[TBL] [Abstract][Full Text] [Related]
5. The Chronic Kidney Disease - Colonic Axis.
Pahl MV; Vaziri ND
Semin Dial; 2015; 28(5):459-63. PubMed ID: 25855516
[TBL] [Abstract][Full Text] [Related]
6. [Uremic toxins and gut micro biome].
Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
[TBL] [Abstract][Full Text] [Related]
7. The consequences of altered microbiota in immune-related chronic kidney disease.
Lau WL; Chang Y; Vaziri ND
Nephrol Dial Transplant; 2021 Sep; 36(10):1791-1798. PubMed ID: 32437554
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.
Hu J; Zhong X; Yan J; Zhou D; Qin D; Xiao X; Zheng Y; Liu Y
BMC Nephrol; 2020 Jan; 21(1):12. PubMed ID: 31931722
[TBL] [Abstract][Full Text] [Related]
9. Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.
Li L; Xiong Q; Zhao J; Lin X; He S; Wu N; Yao Y; Liang W; Zuo X; Ying C
Am J Clin Nutr; 2020 May; 111(5):1087-1099. PubMed ID: 31942927
[TBL] [Abstract][Full Text] [Related]
10. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
Pham NM; Recht NS; Hostetter TH; Meyer TW
Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
[TBL] [Abstract][Full Text] [Related]
11. [Uric acid degradation and biosynthesis of the enzymes uricase, glyoxylate carboligase and urease in Hydrogenomonas H 16. II. Effect of uric acid, fructose and nitrogen deficiency on enzyme formation].
Kaltwasser H
Arch Mikrobiol; 1969; 65(3):288-302. PubMed ID: 4988686
[No Abstract] [Full Text] [Related]
12. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
13. Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition.
Sato E; Hosomi K; Sekimoto A; Mishima E; Oe Y; Saigusa D; Ito S; Abe T; Sato H; Kunisawa J; Niwa T; Takahashi N
Biochem Biophys Res Commun; 2020 May; 525(3):773-779. PubMed ID: 32147096
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
[TBL] [Abstract][Full Text] [Related]
15. The Kidney-Gut-Muscle Axis in End-Stage Renal Disease is Similarly Represented in Older Adults.
Lustgarten MS
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31905970
[TBL] [Abstract][Full Text] [Related]
16. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice.
Guo Y; Yu Y; Li H; Ding X; Li X; Jing X; Chen J; Liu G; Lin Y; Jiang C; Liu Z; He Y; Li C; Tian Z
Eur J Nutr; 2021 Jun; 60(4):2217-2230. PubMed ID: 33104864
[TBL] [Abstract][Full Text] [Related]
17. Can our microbiome break our hearts? Collaborative production of
Machado Ribeiro TR; Brito CB; Byndloss MX
mBio; 2024 Feb; 15(2):e0269223. PubMed ID: 38226819
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease alters intestinal microbial flora.
Vaziri ND; Wong J; Pahl M; Piceno YM; Yuan J; DeSantis TZ; Ni Z; Nguyen TH; Andersen GL
Kidney Int; 2013 Feb; 83(2):308-15. PubMed ID: 22992469
[TBL] [Abstract][Full Text] [Related]
19. p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.
Evenepoel P; Glorieux G; Meijers B
Kidney Int; 2017 Dec; 92(6):1323-1324. PubMed ID: 29153138
[TBL] [Abstract][Full Text] [Related]
20. Microbe-derived uremic solutes enhance thrombosis potential in the host.
Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
mBio; 2023 Nov; 14(6):e0133123. PubMed ID: 37947418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
